Global Infection Surveillance Solutions Market Size, Trends, and Analysis- Forecasts To 2026 By Component (Software, Services (Implementation, Support & Maintenance, and Training & Consulting)), By Deployment Type (On-Premise, Web-Based), By End User (Hospitals, Clinics, Ambulatory Service Centers, Specialty Centers, Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Infection Surveillance Solutions Market: Insights
Infection surveillance solutions are used in the healthcare industry to collect data on nosocomial infections to study the pattern of infections and regulate their spread in the community. Nosocomial infections are infections that are spread to people from hospitals or healthcare centres. Hospital Acquired Infections (HAI) data allow governments to study hospital practices, decreased immunity, poor hygiene, and negligent practices. Infection surveillance solutions allow for easy collection, monitoring, and recording of data related to HAI. The rising number of HAI such as urinary tract infections and surgical site infections has seen a rise in the number of hospitals implementing infection surveillance solutions software. The infections surveillance solutions market is driven by technological advancements, regulations to prevent HAI, increased bacterial resistance to antibiotics, and rising expenditure on health. On the other hand, the cost of implementing such software, and the lack of skilled healthcare IT professionals all hampering the global infection surveillance solutions market.
Infection Surveillance Solutions Market: By Component
The infection surveillance solutions group can be categorized based on the component into software and services. Services include implementation, support & maintenance, and training & consultation. The software segment is the fastest-growing segment as more and more hospitals implement infection surveillance solutions. The software allows for real-time tracking of patient data and efficient monitoring of the hospital’s HAI rates.
Infection Surveillance Solutions Market: By Deployment Type
Based on the deployment type, the market is categorized into on-premise and web-based. The web-based segment is the dominant segment as hospitals prefer them over on-premise as they offer a better return on investment and offer a lot more flexibility than the on-premise software segment.
Infection Surveillance Solutions Market: By End-User
According to the end-user analysis, the market is studied into hospitals, clinics, ambulatory service centers, specialty centers, and others. The hospital segment held the largest share of the market as hospitals are more susceptible to HAI and are scrutinized more heavily by governments. Government regulations have forced hospital’s hands to implement infection surveillance solutions.
Infection Surveillance Solutions Market: By Region
The North American region held the largest market share among all regions. The North American market for infection surveillance solutions is driven by the stricter regulations and the large number of firms offering infection surveillance solutions systems in the region. The large spending by the government on healthcare has seen an increase in the number of healthcare centers as well. The APAC region is the fastest-growing market. The rising awareness regarding health, increased spending on healthcare combined with the rising number of healthcare centers and rapid improvements in health insurance are the major drivers in the region.
Infection Surveillance Solutions Market: Share & Competitor Analysis
Premier Inc., Becton Dickson & Company, Cerner Corporation, Baxter International, PeraHealth Inc., Iatric Systems Inc., DEB Group Ltd, Gojo Industries Inc., Emerald Health Information Systems Ltd, RL Solutions, Hygreen Inc, Wolters Kluwer N.V., bioMerieux Inc., Vigilanz Corporation, ICNet Systems Inc. (Baxter International), Truven Health Analytics Inc, Vecna Technologies Inc, BD Diagnostics, and Quantros Inc. are the key players.
Please note: This is not an exhaustive list of companies profiled in the report.
In 2021, Baxter International reached an agreement to provide sterile manufacturing services to produce the Novavax COVID-19 vaccine.
Check the Press Release on Global Infection Surveillance Solutions Market Report
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Infection Surveillance Solutions Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Infection Surveillance Solutions Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
80% of our clients seek made-to-order reports. How do you want us to tailor yours?